ARTICLE | Politics, Policy & Law
Rate of return on novel drugs
February 19, 2002 8:00 AM UTC
New studies by academic economists bolster the case for providing American senior citizens with a prescription drug benefit while suggesting that price controls and other policies that stifle pharmaceutical innovation are not cost-effective.
Two healthcare economists who are pioneering efforts to sort out the costs and benefits of pharmaceuticals presented the findings at a recent workshop in Washington. ...